Integrin receptor-binding nanofibrous peptide hydrogel for combined mesenchymal stem cell therapy and nitric oxide delivery in renal ischemia/reperfusion injury

Abstract Background Mesenchymal-based therapy has been utilized as a practical approach in the treatment of renal ischemia/reperfusion (I/R) injury. However, low cell retention and survival in the ischemic site have remained challenging issues. To bridge this gap, the integrin receptor-binding RGD p...

詳細記述

書誌詳細

出版年:	Stem Cell Research & Therapy
主要な著者:	Haniyeh Najafi, Samira Sadat Abolmaali, Reza Heidari, Hadi Valizadeh, Ali Mohammad Tamaddon, Negar Azarpira
フォーマット:	論文
言語:	英語
出版事項:	BMC 2022-07-01
主題:	Dipeptide hydrogel RGD peptide Mesenchymal stem cells Nitric oxide donor Renal ischemia/reperfusion injury
オンライン･アクセス:	https://doi.org/10.1186/s13287-022-03045-1